A carregar...

Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer

PURPOSE OF REVIEW: Compensatory mechanisms leading to increased androgen receptor expression and activity after androgen ablation or anti-androgen treatment have been identified in prostate cancer. After hydroxyflutamide and bicalutamide were used in therapy of prostate cancer over many years, novel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Mol Biol Rep
Autor principal: Culig, Zoran
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700216/
https://ncbi.nlm.nih.gov/pubmed/29214142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40610-017-0079-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!